Stem Cell Therapies
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
374
NCT04802733
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: May 3, 2021
Completion: Jun 10, 2024
NCT05363046
Noninterventional Study Evaluating Parkinson's Disease Diary Use
Phase: N/A
Start: Jul 29, 2022
Completion: Oct 31, 2026
NCT05897957
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
Start: May 16, 2023
Completion: Sep 30, 2027
NCT06789445
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Phase: Phase 1/2
Start: Mar 10, 2025
Completion: Oct 31, 2030
NCT06944522
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Phase: Phase 3
Start: Jun 17, 2025
Completion: Mar 31, 2032
Loading map...